Alexis Caulier: Leveraging Epigenetic Silencing in HSCs to Modulate Platelet Aggregation
Alexis Caulier, Assistant Professor, Department of Medicine at McGill University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cell Stem Cell, adding:
“Shoutout to the great Tianyi Ye from The Sankaran Lab for her fantastic work leveraging durable epigenetic silencing in HSCs to modulate platelet aggregation!
A new avenue to prevent cardio-vascular events in high-risk patients?”
Title: Durable and reversible epigenetic programming of human hematopoietic stem cells as a platform for modulation of platelet function
Authors: Tianyi Ye, Wanying Xu, Maria N. Barrachina, Peng Lyu, Mateusz Antoszewski, Lucrezia della Volpe, Chun-Jie Guo, Andrew J. Lee, Emily Villalpando, Isaac A. Johnson, Madelaine S. Theardy, Spencer D. Shelton, Lara Wahlster, Alexis Caulier, Luana Messa, Michael Poeschla, Gaurav Agarwal, Ronodeep Mitra, Alec A. Schmaier, Jonathan S. Weissman, Kellie R. Machlus, Vijay G. Sankaran
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 7, 2026, 12:06Kinza Raza: Giving Back Through Thalassaemia Awareness – A Journey Back to School
-
Nov 7, 2026, 12:03Sean Langenfeld: Rectal Bleeding on Anticoagulation – Don’t Miss Colorectal Cancer
-
Nov 7, 2026, 11:54Sade Oguntola: Modernizing African Traditional Medicine – A New Hope for SCD
-
Nov 7, 2026, 11:44José Antonio García Erce: Patient Blood Management Needs a National Strategy
-
Nov 7, 2026, 11:37Rana Al-Hrout: ITP Treatment in 2026 – Moving Beyond Platelet Counts
-
Nov 7, 2026, 09:00Charlotte Guzzo: MHRA Approves Gene Editing for Younger Children
-
Nov 7, 2026, 08:47Mohammedbaqer Ali Al-Ghuraibawi: Rethinking Aspirin Use After Acute Coronary Syndrome
-
Nov 7, 2026, 08:28Shayan Mohammadmoradi: Targeting Inflammation in Atherosclerosis
-
Nov 7, 2026, 08:15Abdul Mannan: Severe Coagulopathy and the Importance of Drug History